JPRN-UMIN000001604已完成2 期
A comparison of peginterferon alfa-2a plus ribavirin and peginterferon alfa-2b plus ribavirin for. postmenopausal women. with chronic hepatitis type C : An open-label randomized controlled trial. - A comparison of peginterferon alfa-2a plus ribavirin and peginterferon alfa-2b plus ribavirin for. postmenopausal women. with chronic hepatitis type C
Hiroshima liver study group0 个研究点目标入组 80 人开始时间: 2008年12月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Patients receiving shosaiko-to 2)Autoimmune hepatitis 3)History of hypersensitivity to PEG-IFN alpha-2a and PEG-IFN alpha-2b 4)History of hypersensitivity to biological products such as vaccine 5)Decompenstated liver cirrhosis 6)HCC, malignat tumor 7)With or with a history of severe psychosis such as severe depression, suicidal ideation or attempt, etc. 8)Pregnant or lactating women and women who may be pregnant 9)Judged by investigator not to be appropriate for inclusion in this study
研究者
相似试验
已完成
不适用
A comparison of peginterferon ribavirin combination therapies for chronic hepatitis CJPRN-UMIN000000897niversity of Tokyo Department of Gastroenterology, Faculty of Medicine320
进行中（未招募）
不适用
Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection - PARC studyEUCTR2004-004736-30-ATErasmus MC122
进行中（未招募）
不适用
Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection - PARC studychronic HBeAg-negative hepatitis BEUCTR2004-004736-30-DEFoundation of Liver research122
已完成
3 期
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsChronic Hepatitis CNCT00299936Weill Medical College of Cornell University5,000
进行中（未招募）
不适用
Terapia PEG-Interferone alfa 2B+Ribavirina versus terapia PEG-Interferone alfa 2B + Ribavirina+ Terapia ormonale sostitutiva (TOS) nella prevenzione della progressione della fibrosi epatica nell’epatite cronica HCV positiva in eta' post-menopausale - NDWomen in post-menopause with Chronic HCV positive hepatitisMedDRA version: 9.1Level: SOCClassification code 10019805Term: Hepatobiliary disordersEUCTR2008-001260-36-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA